Back to Authors

McAllister, Sean D.

https://orcid.org/0000-0002-1749-1251

A5040951895 | I2801780550

Mayo Clinic

Sutter California Pacific Medical Research Institute, San Francisco, CA, USA

Citations 1

Topical Cannabinoids for Treating Chemotherapy-Induced Neuropathy: A Case Series

Integrative Cancer Therapies | November 29, 2021 | Volume: 20 | Issue: No issue available | Pages: No page available

10.1177/15347354211061739 | PMID 34841942

Background Chemotherapy-induced peripheral neuropathy is a common and often severe side effect from many chemotherapeutic agents, with limited treatment options. There is no literature on the use of topical cannabinoids for chemotherapy-induced neuropathy. Case Presentations The current manuscript presents a case series of patients presenting in oncology clinics at Sutter Health, CA and Mayo Clinic, Rochester, MN from April 2019 to December 2020 with chemotherapy-induced peripheral neuropathy who used topical creams containing the cannabinoids delta-nine-tetrahydrocannabinol (THC) and/or cannabidiol (CBD). Conclusions This case series suggests that topical cannabinoids may be helpful for patients with chemotherapy-induced peripheral neuropathy. This paper also discusses the potential mechanisms of action by which topical cannabinoids might alleviate established CIPN symptoms. A randomized placebo-controlled trial using a standardized product is planned to study the actual efficacy of such treatment.